Annual report pursuant to Section 13 and 15(d)

Note 4 - Acquisitions (Tables)

Note 4 - Acquisitions (Tables)

12 Months Ended

Jun. 30, 2019

Notes Tables

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]

		Preliminary Allocation at Acquisition Date				Adjustments to Fair Value				Final Opening Balance Sheet Allocation
Current assets, net of cash		$	36							$	36
Equipment and other long-term assets			284				(56	)			228
Intangible assets:
Developed technology			20,000				(7,744	)			12,256
Goodwill			9,790				4,691				14,481
Total assets acquired			30,110				(3,109	)			27,001
Liabilities			765				(469	)			296
Deferred income taxes, net			3,741				(2,798	)			943
Net assets acquired		$	25,604			$	158			$	25,762

Cash paid, net of cash acquired		$	20,404			$	58			$	20,462
Fair value of contingent consideration			5,200				100				5,300
Net assets acquired		$	25,604			$	158			$	25,762

		Preliminary Allocation at Acquisition Date				Adjustments to Fair Value				Final Opening Balance Sheet Allocation
Current assets, net of cash		$	5,118				(2,507	)		$	2,611
Equipment and other long-term assets			2,212				-				2,212
Intangible assets:
Developed technology			180,000				(75,000	)			105,000
Trade name			-				58,000				58,000
Customer relationships			-				2,300				2,300
Goodwill			96,592				8,770				105,362
Total assets acquired			283,922				(8,437	)			275,485
Liabilities			2,624				1,092				3,716
Deferred income taxes, net			27,673				(11,327	)			16,346
Net assets acquired		$	253,625			$	1,798			$	255,423

Cash paid, net of cash acquired		$	251,825			$	(202	)		$	251,623
Fair value of contingent consideration			1,800				2,000				3,800
Net assets acquired		$	253,625			$	1,798			$	255,423

		Preliminary Allocation at Acquisition Date
Current assets, net of cash		$	504
Equipment and other long-term assets			269
Intangible assets:
Developed technology			14,000
Customer relationships			400
Goodwill			16,457
Total assets acquired			31,630
Liabilities			211
Deferred income taxes, net			3,377
Net assets acquired		$	28,042

Cash paid, net of cash acquired		$	17,448
Fair value of contingent consideration			5,500
Fair value of historical investment in B-MoGen			5,094
Net assets acquired		$	28,042

Business Acquisition, Pro Forma Information [Table Text Block]

		Year Ended
		June 30,
		2017				2016
Net sales		$	564,220			$	523,840
Net income			99,380				110,536

Schedule of Business Acquisitions, by Acquisition [Table Text Block]

		Trevigen			Atlanta Biologicals			Eurocell Diagnostics				ACD				Space
Current assets, net of cash	$	1,662		$	15,722			$	512			$	15,824			$	2,128
Equipment and other long-term assets		53			4,901				188				6,569				159
Intangible assets:
Developed technology		5,100			23,000				-				150,000				-
Trade name		160			2,300				-				21,900				-
Customer relationships		260			3,600				6,272				6,300				6,769
Goodwill		5,991			10,195				2,910				143,967				3,517
Total assets acquired		13,226			59,718				9,882				344,560				12,573

Liabilities		387			90				483				4,179				1,445
Deferred income taxes, net		2,195			8,354				2,070				52,743				2,125
Net assets acquired	$	10,644		$	51,274			$	7,329			$	287,638			$	9,003

Cash paid, net of cash acquired		10,644			51,274			$	5,933			$	247,038			$	6,747
Consideration payable		-			-				1,396				3,600				2,256
Contingent consideration payable		-			-				-				37,000				-
Net assets acquired	$	10,644		$	51,274			$	7,329			$	287,638			$	9,003